SPL 1.00% 9.9¢ starpharma holdings limited

viraleze success in the real world

  1. 12,754 Posts.
    lightbulb Created with Sketch. 1369
    Just a reminder

    Viraleze has been successful in the lab against every single variant that was tested

    Viraleze has been in a first in human trial for safety and there has been no serious adverse effects

    Viraleze has been tested in the lab for pre and post covid infections and has been found to reduce viral load

    Starpharma has been selling Viraleze under license multiple tens of thousands or possibly hundreds of thousands of units in the global market for last 2 years and the anecdotal evidence for preventative and protection has been overwhelmingly positive

    We will have the results shorly
    Why is it taking so long. Who knows. We can only speculate. Maybe the data was brilliant and there was enough information to expand the results to indications for RSV, Influenza A&B etc etc
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
-0.001(1.00%)
Mkt cap ! $40.79M
Open High Low Value Volume
10.0¢ 10.5¢ 9.9¢ $24.18K 241.6K

Buyers (Bids)

No. Vol. Price($)
1 2499 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 428888 7
View Market Depth
Last trade - 16.10pm 13/06/2024 (20 minute delay) ?
Last
10.0¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
10.3¢ 10.5¢ 10.0¢ 168392
Last updated 15.48pm 13/06/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.